ReviewIntensive care medicine2026
How to optimize brain perfusion and prevent cerebral complications during extracorporeal life support.
Review in Intensive care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracorporeal life support (ECLS) is increasingly used to rescue patients with refractory respiratory failure, cardiogenic shock and/or cardiac arrest. Acute brain injury during ECLS is common and associated with a significant increase in mortality and long-term disability. Brain injury in ECLS patients can arise from either the underlying disease or pre-ECLS events, such as cardiac arrest, or from secondary mechanisms linked to ECLS-related complications, management strategies, and physiologic perturbations during support. In this review, we will focus on the modifiable factors and clinical management strategies to prevent or mitigate secondary brain injury during ECLS. Both veno-arterial membrane oxygenation (VA-ECMO) as well as veno-venous membrane oxygenation (VV-ECMO) will be discussed. First, we provide an overview of the interplay between patient and circuit related factors that determine brain perfusion and oxygen delivery in this critically ill patient population. Second, we highlight the importance of standardized multimodal neuromonitoring to detect evolving brain injury early and to guide individualized neurocritical care and ECLS management. Third, we identify modifiable ECLS factors and physiological targets which minimize secondary brain injury. We provide guidance on the titration of extracorporeal blood flow and blood pressure targets, the amount of sweep gas flow and oxygen fraction, temperature control and anticoagulation management. A comprehensive understanding of ECLS physiology and circuit-patient interactions, integrated with protocolized multimodal monitoring, enables individualized adjustment of modifiable ECLS settings to prevent or mitigate secondary brain injury.
Indexed as
Identifiers
42315625What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.